BFM
PRAX icon

Boothbay Fund Management’s Praxis Precision Medicines PRAX Stock Holding History

Boothbay Fund Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.02M Buy
17,968
+381
+2% +$121K 0.08% 292
2026
Q1 		$5.67M Sell
17,587
-3,387
-16% -$1.05M 0.07% 286
2025
Q4 		$6.18M Sell
20,974
-18,686
-47% -$3.48M 0.09% 238
2025
Q3 		$2.1M Sell
39,660
-78,461
-66% -$3.8M 0.03% 558
2025
Q2 		$4.97M Buy
118,121
+71,495
+153% +$2.72M 0.1% 294
2025
Q1 		$1.77M Buy
+46,626
New +$2.91M 0.05% 455
2024
Q3 		– Sell
-6,368
Closed -$263K – 1861
2024
Q2 		$263K Sell
6,368
-36,435
-85% -$1.72M 0.01% 1196
2024
Q1 		$2.61M Sell
42,803
-3,907
-8% -$175K 0.05% 415
2023
Q4 		$1.04M Buy
46,710
+16,500
+55% +$297K 0.03% 721
2023
Q3 		$775K Buy
+30,210
New +$572K 0.02% 869
2023
Q2 		– Sell
-4,750
Closed -$57.6K – 2198
2023
Q1 		$57.6K Buy
4,750
+3,046
+179% +$129K ﹤0.01% 2011
2022
Q4 		$60.8K Buy
+1,704
New +$53.1K ﹤0.01% 1866
2021
Q4 		– Sell
-724
Closed -$201K – 2146
2021
Q3 		$201K Buy
+724
New +$196K 0.01% 1584

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Boothbay Fund Management's PRAX Position: Q2 2026 in Review

Boothbay Fund Management increased its Praxis Precision Medicines (PRAX) stake by 2.2% in Q2 2026, buying an estimated $121K and bringing the position to 17,968 shares worth $6.02M. The position accounts for 0.08% of the portfolio, ranked #292.

Boothbay Fund Management first reported a position in PRAX in Q3 2021 and has held it in 13 quarters since. The position peaked at $6.18M in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Boothbay Fund Management held 17,968 shares of Praxis Precision Medicines worth $6.02M as of Q2 2026.
  • Boothbay Fund Management bought 381 Praxis Precision Medicines shares in Q2 2026, an estimated $121K.
  • Praxis Precision Medicines made up 0.08% of Boothbay Fund Management's portfolio in Q2 2026, its #292 holding.
  • Boothbay Fund Management first reported a position in Praxis Precision Medicines in Q3 2021 and has held it in 13 quarters since.
  • Boothbay Fund Management's Praxis Precision Medicines position peaked at $6.18M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.